Related Experiment Videos
[Acute hepatotoxicity from amiodarone]
C Tosetti1, M Ongari, A Evangelisti
1Divisione di Medicina Generale, Azienda USL Bologna Sud, Ospedale Civile di Porretta Terme, Bologna.
Minerva Medica
|September 1, 1995
Summary
Amiodarone can cause acute liver injury, including hepatocytonecrosis, even after the first dose. This liver damage may involve toxic, immunogenic, or idiosyncratic mechanisms, necessitating further investigation.
Area of Science:
- Hepatology
- Clinical Pharmacology
Background:
- Amiodarone is associated with known liver function alterations, including elevated transaminases and phospholipidosis during long-term use.
- Previous reports highlight acute liver injury and fatal cases linked to amiodarone treatment.
Observation:
- This study identified acute hepatocytonecrosis and impaired protein synthesis after the initial amiodarone dose.
- These laboratory abnormalities resolved upon drug discontinuation.
Findings:
- The findings suggest amiodarone can induce rapid hepatotoxicity beyond previously recognized chronic effects.
- Acute liver injury may manifest as hepatocytonecrosis and compromised liver synthetic function.
Implications:
- Beyond dose-dependent toxicity, immunogenic or idiosyncratic pathways may contribute to amiodarone-induced acute liver injury.
- Early identification and understanding of these mechanisms are crucial for patient safety and management.